4/19
08:03 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
High
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
4/16
11:15 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
Low
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
4/16
11:15 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
Low
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
4/16
11:10 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
4/16
11:10 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
3/13
11:32 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
3/13
11:32 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
3/12
10:08 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
3/12
10:08 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
2/14
08:03 am
ocul
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
High
Report
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.